Tourette syndrome
Conditions
Interventions
Test group:Choudongning capsule
positive control group:Tiapride Hydrochloride Tablets
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
4 Years to 18 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed as Tourette syndrome (TCM differentiation of phlegm stasis due to spleen deficiency ); 2. Aged between 4 and 18 years old; 3. Written ICF obtained from a legally acceptable representative & informed assent at Baseline as applicable by trial center's IRB/IEC.
Exclusion criteria
Exclusion criteria: 1. Involuntary movement caused by other diseases, such as rheumatism chorea, Huntington's disease, hepatolenticular degeneration, athetosis, myoclonus, acute movement disorder, hysteria seizures, epilepsy and childhood schizophrenia, drug-induced extrapyramidal symptoms and other extrapyramidal disease; 2. Transient tic disorder or Tourette associated with ADHD; 3. Epileptiform discharges were found through EEG; 4. Combined with cardiovascular, kidney and hematopoietic system or any primary disease; 5. Allergic constitution ( for two or more substances allergies ) or the preparation of known composition allergies; 6. Inability to swallow capsule or tolerate oral medication or those who are participating in other trials; 7. Those who are inclined to lose follow-up based on the investigators judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Yale Global Tic Severity Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome scale; | — |
Countries
China
Contacts
Public ContactRong Ma
Tianjin University of Traditional Chinese Medicine
Outcome results
None listed